2023 - Research.com Medicine in United Kingdom Leader Award
Paul D.P. Pharoah mainly focuses on Breast cancer, Internal medicine, Genetics, Oncology and Genome-wide association study. Breast cancer is a subfield of Cancer that he tackles. In most of his Internal medicine studies, his work intersects topics such as Endocrinology.
Paul D.P. Pharoah interconnects Pathology, Genetic counseling, Penetrance, Tissue microarray and Genetic testing in the investigation of issues within Oncology. His Genome-wide association study study necessitates a more in-depth grasp of Single-nucleotide polymorphism. Paul D.P. Pharoah has researched Single-nucleotide polymorphism in several fields, including Case-control study, Polymorphism and Genetic variation.
Paul D.P. Pharoah mainly investigates Internal medicine, Breast cancer, Oncology, Single-nucleotide polymorphism and Genetics. His study in Internal medicine focuses on Cancer, Odds ratio, Ovarian cancer, Case-control study and Prostate cancer. His Cancer research integrates issues from Candidate gene, Endocrinology and Risk factor.
Paul D.P. Pharoah combines subjects such as Cancer research, Genetic predisposition and Bioinformatics with his study of Breast cancer. His Oncology study integrates concerns from other disciplines, such as Disease, Pathology, Gynecology, Proportional hazards model and Hazard ratio. Single-nucleotide polymorphism is a subfield of Genotype that Paul D.P. Pharoah studies.
Paul D.P. Pharoah mostly deals with Internal medicine, Oncology, Breast cancer, Genome-wide association study and Cancer. Many of his studies involve connections with topics such as Single-nucleotide polymorphism and Internal medicine. The study incorporates disciplines such as Logistic regression, Genotyping and Gene–environment interaction in addition to Single-nucleotide polymorphism.
His Oncology research is multidisciplinary, relying on both Prostate, MEDLINE, Ovarian cancer, Disease and Genotype. His Breast cancer research incorporates elements of Cancer research, Genetic variants, Germline and Hazard ratio. His Genome-wide association study research is under the purview of Genetics.
The scientist’s investigation covers issues in Internal medicine, Oncology, Breast cancer, Cancer and Genome-wide association study. His research integrates issues of PALB2, Confidence interval, Proportional hazards model, Prostate cancer and Cohort in his study of Oncology. His research in Breast cancer intersects with topics in Germline mutation, Bioinformatics, Genetic testing and Hazard ratio.
His Cancer study combines topics in areas such as Myeloid, Cancer research, CHEK2 and MEDLINE. Genome-wide association study is the subject of his research, which falls under Single-nucleotide polymorphism. His Case-control study research includes elements of Demography and Genotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A. Antoniou;P.D.P. Pharoah;S. Narod;H.A. Risch.
American Journal of Human Genetics (2003)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi.
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Gillian C. Barnett;Gillian C. Barnett;Charlotte E. Coles;Rebecca M. Elliott;Caroline Baynes.
Lancet Oncology (2012)
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks.
PLOS Medicine (2010)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira;Suet Feung Chin;Oscar M. Rueda;Hans Kristian Moen Vollan.
Nature Communications (2016)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Polygenic susceptibility to breast cancer and implications for prevention
Paul D.P. Pharoah;Antonis Antoniou;Martin Bobrow;Ron L. Zimmern.
Nature Genetics (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: